ES405544A1 - Procedimiento para preparar derivados de propanolamina. - Google Patents

Procedimiento para preparar derivados de propanolamina.

Info

Publication number
ES405544A1
ES405544A1 ES405544A ES405544A ES405544A1 ES 405544 A1 ES405544 A1 ES 405544A1 ES 405544 A ES405544 A ES 405544A ES 405544 A ES405544 A ES 405544A ES 405544 A1 ES405544 A1 ES 405544A1
Authority
ES
Spain
Prior art keywords
phenoxypropanolamines
heterocyclic derivatives
treatment
pharmaceutical compositions
heterocyclic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES405544A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp
Original Assignee
Pfizer Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp filed Critical Pfizer Corp
Publication of ES405544A1 publication Critical patent/ES405544A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/32—One oxygen atom
    • C07D233/36—One oxygen atom with hydrocarbon radicals, substituted by nitrogen atoms, attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/84—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D263/06—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
ES405544A 1971-08-04 1972-08-04 Procedimiento para preparar derivados de propanolamina. Expired ES405544A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3660671 1971-08-04

Publications (1)

Publication Number Publication Date
ES405544A1 true ES405544A1 (es) 1975-07-16

Family

ID=10389666

Family Applications (1)

Application Number Title Priority Date Filing Date
ES405544A Expired ES405544A1 (es) 1971-08-04 1972-08-04 Procedimiento para preparar derivados de propanolamina.

Country Status (13)

Country Link
US (1) US3852291A (es)
JP (1) JPS587629B2 (es)
AR (3) AR196078A1 (es)
AU (1) AU461863B2 (es)
BE (1) BE787103A (es)
CA (1) CA996112A (es)
CH (1) CH555342A (es)
DE (1) DE2238504C3 (es)
ES (1) ES405544A1 (es)
FR (1) FR2150728B1 (es)
GB (1) GB1345075A (es)
IE (1) IE36611B1 (es)
SE (1) SE409862B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4195090A (en) * 1973-02-20 1980-03-25 Ciba-Geigy Corporation 2-(3-Amino-2-hydroxy-propoxy)pyridine derivatives and pharmaceutical compositions therewith
US4410530A (en) * 1973-02-20 1983-10-18 Ciba-Geigy Corporation 2-(3-Amino-2-hydroxy-propoxy)-mono-and diazines
US4020071A (en) * 1973-12-20 1977-04-26 Cassella Farbwerke Mainkur Aktiengesellschaft Derivatives of 1-phenoxy-3-amino-propan-2-ol
US4066768A (en) * 1973-12-27 1978-01-03 Cassella Farbwerke Mainkur Aktiengesellschaft Derivatives of 1-phenoxy-3-amino-propan-2-ol
US4088764A (en) * 1973-12-27 1978-05-09 Cassella Farbwerke Mainkur Aktiengesellschaft Pharmaceutically active derivatives of 1-phenoxy-3-amino-propan-2-ol
US4041076A (en) 1974-10-23 1977-08-09 Hoffmann-La Roche Inc. Immunoassay for pharmacologically active phenethylamines
DE2609645A1 (de) * 1976-03-09 1977-09-15 Boehringer Sohn Ingelheim Aminoalkylheterocyclen
DE2644833A1 (de) * 1976-10-05 1978-04-20 Boehringer Sohn Ingelheim Neue 1-aryloxy-2-hydroxy-3-alkylenaminopropane und verfahren zu ihrer herstellung
LU77339A1 (es) * 1977-05-16 1979-01-19
US4234595A (en) * 1977-07-13 1980-11-18 Mead Johnson & Company 3-Indolyl-tertiary butylaminopropanols
DE2833140A1 (de) * 1978-07-28 1980-02-07 Boehringer Sohn Ingelheim Neue n-substituierte heterocyclen
US4319032A (en) * 1980-06-06 1982-03-09 Alcolac Inc. Derivatives of aminoalkyl alkylene ureas
DE3023369A1 (de) * 1980-06-23 1982-01-14 Boehringer Mannheim Gmbh, 6800 Mannheim Aryloxypropanolamine, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
CA1269378A (en) * 1981-10-23 1990-05-22 George Emile Abboud Polymerisable monomers, polymer dispersions and derived paints
FR2523965B1 (fr) * 1982-03-24 1985-09-27 Bellon Labor Sa Roger (benzimidazolyl-1)-1, n-((hydroxy-4 methoxy-3 phenyl)-2 hydroxy-2 ethyl) amino-3 butane et ses sels a activite b-adrenergique, leurs applications therapeutiques, et procede pour les preparer
US4634713A (en) * 1982-05-28 1987-01-06 Ciba-Geigy Corporation Antihypertensive 3-(ureidocyclohexyleneamino)propane-1,2-diol derivatives
IT1193608B (it) * 1983-01-21 1988-07-21 Pierrel Spa Derivati di arilossipropanolamina,procedimento per la loro preparazione composizioni farmaceutiche che li contengono e loro impiego terapeutico
US4593039A (en) * 1984-04-02 1986-06-03 Merck & Co., Inc. 1-aryloxy-3-(substituted aminoalkylamino)-2-propanols
US5008267A (en) * 1988-10-29 1991-04-16 Mitsui Toatsu Chemicals, Incorporated Pyrimidinedione compounds, method of producing the same and antiarrythmic agents containing the same
JP2815218B2 (ja) * 1990-04-13 1998-10-27 三井化学株式会社 ピリミジンジオン誘導体、およびそれを含有する抗不整脈剤

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2883381A (en) * 1959-04-21 New process for the production of hy-
CH546242A (de) * 1969-01-24 1974-02-28 Ciba Geigy Ag Verfahren zur herstellung von neuen dialkoholen von zwei n-heterocyclische ringe enthaltenden verbindungen.

Also Published As

Publication number Publication date
IE36611L (en) 1973-02-04
FR2150728A1 (es) 1973-04-13
JPS587629B2 (ja) 1983-02-10
US3852291A (en) 1974-12-03
AU4541772A (en) 1974-02-14
JPS4828467A (es) 1973-04-14
SE409862B (sv) 1979-09-10
DE2238504C3 (de) 1980-03-20
IE36611B1 (en) 1976-12-08
CA996112A (en) 1976-08-31
FR2150728B1 (es) 1976-04-16
DE2238504A1 (de) 1973-02-22
AR196078A1 (es) 1973-11-30
AU461863B2 (en) 1975-06-05
GB1345075A (en) 1974-01-30
AR196011A1 (es) 1973-11-23
CH555342A (de) 1974-10-31
BE787103A (fr) 1973-02-02
AR197038A1 (es) 1974-03-08
DE2238504B2 (de) 1979-07-19

Similar Documents

Publication Publication Date Title
ES405544A1 (es) Procedimiento para preparar derivados de propanolamina.
ES373606A1 (es) Un procedimiento para la preparacion de nuevos derivados depropanolamina.
BE772723A (fr) Procede de preparation de nouvelles alpha-aminopenicillines, penicillines ainsi obtenues et compositions pharmaceutiques les contenant
PH13755A (en) N,n-dialkyl cabamoyl-piperazine derivatives,pharmaceutical compositions containing same and process for the induction of endocenous interferon using same
IL37815A0 (en) Indoline derivatives,their manufacture and pharmaceutical compositions containing them
AU468490B2 (en) Furylmethyl morphinane derivatives and pharmaceutical compositions containing them
IL37816A0 (en) Indoline derivatives,their manufacture and pharmaceutical compositions containing them
ZA71221B (en) New pharmaceutical compositions for the treatment of microbial infections
PH9827A (en) Derivatives of 1-phenoxy-3-amino-propane-2-ol and composition thereof
IL40931A0 (en) Tetrahydrocarbazole derivatives,their manufacture and pharmaceutical compositions containing them
CA954536A (en) Ceramic composition and process of making the same
IL43726A0 (en) Novel propanolamine derivatives and pharmaceutical compositions containing them
PH11231A (en) Piperidinesulfonylurea derivatives and pharmaceutical compositions containing them
ZA711512B (en) Heterocyclic derivatives and pharmaceutical compositions thereof
IL42353A0 (en) New derivatives of propanolamine,their manufacture and pharmaceutical compositions containing them
IL37102A (en) Benzoyloxyalkyl penicillins,their manufacture and pharmaceutical compositions containing them
BE761713A (fr) Nouvelles pyrrolidines substituees, leur preparation et compositions pharmaceutiques les contenant
AU462834B2 (en) Pharmaceutical composition and method of treatment
ZA741259B (en) Pharmaceutical compositions and methods of using the same
IL37234A0 (en) Thiazole derivatives,their manufacture and pharmaceutical compositions containing them
IL37702A0 (en) Phenethylamide derivatives,their manufacture and pharmaceutical compositions containing them
BE782924A (fr) Nouvelles tetrahydroquinoleines substituees et compositions pharmaceutiques les contenant
IL36608A0 (en) Halogenosteroids of the pregnane series,their manufacture and pharmaceutical compositions containing them
CA965090A (en) N-substituted heterocyclic derivatives and preparation thereof
CA1017674A (en) Pharmaceutical composition useful as an anti-depressant agent and an anti-parkinsonism agent